Iddo Magen
Affiliations: | Weizmann Institute of Science, Rehovot, Israel |
Google:
"Iddo Magen"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Magen I, Yacovzada NS, Warren JD, et al. (2023) microRNA-based predictor for diagnosis of frontotemporal dementia. Neuropathology and Applied Neurobiology. e12916 |
| Magen I, Aharoni S, Yacovzada NS, et al. (2022) Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients. European Journal of Neurology |
| Magen I, Yacovzada NS, Yanowski E, et al. (2021) Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis. Nature Neuroscience. 24: 1534-1541 |
| Reichenstein I, Eitan C, Diaz-Garcia S, et al. (2019) Human genetics and neuropathology suggest a link between miR-218 and amyotrophic lateral sclerosis pathophysiology. Science Translational Medicine. 11 |
| Coenen-Stass AML, Magen I, Brooks T, et al. (2018) Evaluation of methodologies for microRNA biomarker detection by next generation sequencing. Rna Biology. 1-13 |
| Rotem N, Magen I, Ionescu A, et al. (2017) ALS Along the Axons - Expression of Coding and Noncoding RNA Differs in Axons of ALS models. Scientific Reports. 7: 44500 |
| Emde A, Eitan C, Liou LL, et al. (2015) Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS. The Embo Journal. 34: 2633-51 |
| Magen I, Hornstein E. (2014) Oligonucleotide-based therapy for neurodegenerative diseases. Brain Research. 1584: 116-28 |